You have 9 free searches left this month | for more free features.

AIDS-related peripheral/systemic lymphoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

Active, not recruiting
  • AIDS-Related Burkitt Lymphoma
  • +5 more
  • Bethesda, Maryland
    NCI Lymphoid Malignancies Branch
Jul 31, 2022

AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte

Active, not recruiting
  • AIDS-related Non-Hodgkin Lymphoma
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

AIDS Related Lymphoma and Lympholeukemia Trial in Hangzhou (ThisCART19A)

Recruiting
  • AIDS Related Lymphoma and Lympholeukemia
  • ThisCART19A
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Apr 17, 2022

Collecting Blood and Tissue Sample Donations for Research for

Not yet recruiting
  • Anal Carcinoma
  • +11 more
  • Biospecimen Collection
  • (no location specified)
Dec 21, 2022

Tool to Describe HIV-Related Cancer Burden and Patient

Not yet recruiting
  • HIV-Associated Malignant Neoplasm
  • +7 more
  • Non-Interventional
  • Non-Interventional Follow-up
  • (no location specified)
Aug 18, 2022

AIDS Related Lymphoma, AIDS-Associated Lymphoma Trial run by the NCI (Filgrastim, Rituximab, EPOCH)

Completed
  • AIDS Related Lymphoma
  • AIDS-Associated Lymphoma
  • Filgrastim
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 18, 2022

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

Recruiting
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Microdevices
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 16, 2022

AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))

Terminated
  • AIDS-related Lymphoma
  • HIV Infections
  • PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 4, 2022

Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse Trial run by the NCI (Rituximab, Filgrastim, EPOCH)

Active, not recruiting
  • Lymphoma, AIDS-related
  • Lymphoma, Large B-Cell, Diffuse
  • Rituximab
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2022

Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular T-Cell

Recruiting
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • +13 more
  • Brentuximab Vedotin
  • Pembrolizumab
  • Chicago, Illinois
    Northwestern University
Jun 15, 2022

Clinical and Genomic Factors for Prognosis of AIDS Primary

Recruiting
  • AIDS-Related Primary Effusion Lymphoma
  • Laboratory Biomarker Analysis
  • Medical Chart Review
  • La Jolla, California
  • +5 more
Jan 21, 2022

Lymphoma, Non-Hodgkin, HIV Trial in New Orleans (Methotrexate, Leucovorin calcium, Zidovudine)

Terminated
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • New Orleans, Louisiana
    Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU
Oct 27, 2021

AIDS Related Lymphoma, HIV Related Lymphoma Trial in Worldwide

Recruiting
  • AIDS Related Lymphoma
  • HIV Related Lymphoma
    • Munich, Select One Option, Germany
    • +5 more
    Jan 28, 2022

    Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Diffuse Large Cell Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin)

    Completed
    • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
    • Fairport, New York
      Rochester Skin Lymphoma Medical Group
    Aug 24, 2022

    Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

    Not yet recruiting
    • Leukemia
    • +12 more
    • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
    • (no location specified)
    Mar 20, 2023

    People Living With HIV Treated With CD19-directed CAR T Cell

    Active, not recruiting
    • Leukemia
    • +9 more
      • Philadelphia, Pennsylvania
        Pennsylvania Hospital
      Mar 29, 2023

      Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

      Terminated
      • Acute Biphenotypic Leukemia
      • +29 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 4, 2023

      HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

      Recruiting
      • HIV Infection
      • +10 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +7 more
      • La Jolla, California
      • +3 more
      Dec 7, 2022

      AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection Trial (Axicabtagene Ciloleucel,

      Not yet recruiting
      • AIDS-Related Diffuse Large B-cell Lymphoma
      • +14 more
      • Axicabtagene Ciloleucel
      • +2 more
      • (no location specified)
      Feb 15, 2022

      Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

      Available
      • Epstein-Barr Virus (EBV) Infections
      • +11 more
      • tabelecleucel
      • (no location specified)
      Feb 15, 2022

      Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

      Active, not recruiting
      • Acute Leukemia
      • +14 more
      • Duarte, California
        City of Hope Medical Center
      Nov 18, 2022

      Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee

      Completed
      • Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
      • Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
      • CliniMACS (CD+3, CD+19 depletion)
      • +2 more
      • Milwaukee, Wisconsin
        Children's Hospital of Wisconsin
      Oct 21, 2021